E2F3 and gastric cancer: A novel study suggested that 1,25(OH)2D3 inhibited proliferation of gastric cancer cells via regulation of miR-145 and its target E2F3 and targeting vitamin D/miR-145/E2F3 pathway will be a potential strategy for gastric cancer treatment [47].